145 related articles for article (PubMed ID: 30677053)
1. A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.
van Maaren MC; Kneepkens RF; Verbaan J; Huijgens PC; Lemmens VEPP; Verhoeven RHA; Siesling S
PLoS One; 2019; 14(1):e0210887. PubMed ID: 30677053
[TBL] [Abstract][Full Text] [Related]
2. Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years.
van Maaren MC; Strobbe LJA; Smidt ML; Moossdorff M; Poortmans PMP; Siesling S
Eur J Cancer; 2018 Oct; 102():82-94. PubMed ID: 30144661
[TBL] [Abstract][Full Text] [Related]
3. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
4. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
5. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
[TBL] [Abstract][Full Text] [Related]
6. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
[TBL] [Abstract][Full Text] [Related]
7. Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?
van Erning FN; van Steenbergen LN; Lemmens VEPP; Rutten HJT; Martijn H; van Spronsen DJ; Janssen-Heijnen MLG
Eur J Cancer; 2014 Jul; 50(10):1731-1739. PubMed ID: 24814358
[TBL] [Abstract][Full Text] [Related]
8. Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands.
Janssen-Heijnen ML; van Steenbergen LN; Voogd AC; Tjan-Heijnen VC; Nijhuis PH; Poortmans PM; Coebergh JW; van Spronsen DJ
Ann Oncol; 2014 Jan; 25(1):64-8. PubMed ID: 24201973
[TBL] [Abstract][Full Text] [Related]
9. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
10. The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study.
Poodt IGM; Rots ML; Vugts G; van Dalen T; Kuijer A; Vriens BEPJ; Nieuwenhuijzen GAP; Schipper RJ
Eur J Surg Oncol; 2018 Aug; 44(8):1151-1156. PubMed ID: 29580733
[TBL] [Abstract][Full Text] [Related]
11. Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.
Witteveen A; Vliegen IM; Sonke GS; Klaase JM; IJzerman MJ; Siesling S
Breast Cancer Res Treat; 2015 Aug; 152(3):627-36. PubMed ID: 26162567
[TBL] [Abstract][Full Text] [Related]
12. Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study.
Rookus MA; van Leeuwen FE
J Natl Cancer Inst; 1996 Dec; 88(23):1759-64. PubMed ID: 8944006
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer diagnosis and death in the Netherlands: a changing burden.
van der Waal D; Verbeek AL; den Heeten GJ; Ripping TM; Tjan-Heijnen VC; Broeders MJ
Eur J Public Health; 2015 Apr; 25(2):320-4. PubMed ID: 24972595
[TBL] [Abstract][Full Text] [Related]
14. Prognosis for long-term survivors of cancer.
Janssen-Heijnen ML; Houterman S; Lemmens VE; Brenner H; Steyerberg EW; Coebergh JW
Ann Oncol; 2007 Aug; 18(8):1408-13. PubMed ID: 17693654
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
16. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
17. Variation in management of early breast cancer in the Netherlands, 2003-2006.
van Steenbergen LN; van de Poll-Franse LV; Wouters MW; Jansen-Landheer ML; Coebergh JW; Struikmans H; Tjan-Heijnen VC; van de Velde CJ
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S36-43. PubMed ID: 20620013
[TBL] [Abstract][Full Text] [Related]
18. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
19. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
